Touch Oncology

  • Home
  • Touch Oncology

Touch Oncology touchONCOLOGY.com hosts the expert content from peer-reviewed, free-to-access journals – EU Oncology

At touchONCOLOGY, we push the boundaries of online medical education to bring you innovative formats and valuable insights into learning behaviours. Our educational content enhances your ability to provide better patient care and drive positive change in clinical practice. With patients at the heart of everything we do, we aim to help you significantly improve health outcomes. This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.

Some symptoms of myeloma can be easy to overlook.Shortness of breath. Extreme fatigue. Bones that break easily.These can...
08/09/2026

Some symptoms of myeloma can be easy to overlook.

Shortness of breath. Extreme fatigue. Bones that break easily.

These can have many possible causes, but they can also be signs of multiple myeloma and should not be ignored when persistent or unexplained.

Recognising potential symptoms is an important part of improving awareness and supporting timely investigation.

This Blood Cancer Awareness Month, take a moment to .

Explore myeloma signs, diagnosis and management: https://touchhaematology.com/speciality/myeloma/

📢 How can culturally sensitive communication improve care for patients with glioblastoma?At , Dr Jigisha Thakkar shared...
08/09/2026

📢 How can culturally sensitive communication improve care for patients with glioblastoma?

At , Dr Jigisha Thakkar shared research exploring how cultural and ethnic differences influence communication preferences among patients with glioblastoma and their caregivers.

The findings suggest that tailoring discussions around information sharing, decision-making and family involvement may improve patient satisfaction, strengthen patient–provider relationships and help reduce caregiver stress.

🔗 Read more: https://touchoncology.com/insight/glioblastoma-cultural-understanding/

📢 What were the key lung cancer developments at ASCO 2026?In this expert perspective, Dr Federico Monaca reviews eight m...
07/09/2026

📢 What were the key lung cancer developments at ASCO 2026?

In this expert perspective, Dr Federico Monaca reviews eight major lung cancer abstracts from ASCO 2026, highlighting advances across targeted therapies, antibody-based approaches and peri-operative treatment strategies.

As thoracic oncology continues to evolve, the focus is shifting from proof-of-concept to questions of optimization, sequencing and real-world implementation.

Read more: https://touchoncology.com/insight/lung-cancer-asco-2026/

ASCO 2026 | NSCLC brain metastases and the rise of ADCsAs ASCO 2026 brings together the global oncology community, CNS d...
04/09/2026

ASCO 2026 | NSCLC brain metastases and the rise of ADCs

As ASCO 2026 brings together the global oncology community, CNS disease in advanced NSCLC remains a major clinical challenge, with an urgent need for new treatment approaches.

An emerging and important development is the growing role of antibody–drug conjugates (ADCs), with early evidence of intracranial activity in patients with brain metastases.

Find out more on this important topic in touchIME’s CE/CME-accredited touchPANEL DISCUSSION:
Targeting brain metastases in advanced NSCLC: The emerging impact of ADCs
https://touchoncologyime.org/nsclc-brain-mets-adcs/

A timely resource alongside ASCO 2026, as data and practice continue to evolve in this complex space.

🩺 Urine isn’t waste. It’s wisdom.We flush it away every day, but urine can provide valuable clues about our health.Chang...
03/09/2026

🩺 Urine isn’t waste. It’s wisdom.

We flush it away every day, but urine can provide valuable clues about our health.

Changes in colour, odour, frequency or the presence of blood may sometimes warrant further investigation.

💙 This , we’re proud to support The Urology Foundation’s campaign, helping raise awareness of the importance of paying attention to urinary health.

👀 Take control. Check your urine.

🔎 Explore our genitourinary cancer resources:
https://touchoncology.com/speciality/genitourinary-cancers/

European Association of Urology World Bladder Cancer Patient Coalition

🧬 Bridging the evidence gap in small bowel adenocarcinomaSmall bowel adenocarcinoma (SBA) remains a rare but aggressive ...
03/09/2026

🧬 Bridging the evidence gap in small bowel adenocarcinoma

Small bowel adenocarcinoma (SBA) remains a rare but aggressive gastrointestinal malignancy, with limited evidence to guide treatment and persistently poor outcomes in advanced disease.

This review outlines current standards of care, which are largely extrapolated from colorectal cancer, alongside the role of biomarker-selected therapies such as immunotherapy in a small subset of patients.

Read more: https://touchoncology.com/gastrointestinal-cancers/journal-articles/bridging-the-evidence-gap-in-small-bowel-adenocarcinoma-current-standards-biomarker-selected-therapies-and-novel-antibody-drug-conjugate-based-clinical-initiatives/

🌍 The World Bladder Cancer Patient Coalition is organising the World Bladder Cancer Patient Forum 2026 in Hong Kong on 2...
02/09/2026

🌍 The World Bladder Cancer Patient Coalition is organising the World Bladder Cancer Patient Forum 2026 in Hong Kong on 21–22 September, and we’d love for you to be part of it.

When advocacy is recognised and reinforced, patients are more likely to receive coordinated, informed and patient-centred care. Together, we can make that happen.

📌 Registrations are open, join advocates from around the world.
🔗 https://worldbladdercancer.glueup.com/event/world-bladder-cancer-patient-forum-2026-186166/home.html

September is Blood Cancer Awareness Month. 🩸This month, we’re supporting the International Myeloma Foundation’s campai...
01/09/2026

September is Blood Cancer Awareness Month. 🩸

This month, we’re supporting the International Myeloma Foundation’s campaign to help raise awareness of multiple myeloma.

Myeloma is a blood cancer that develops in plasma cells, a type of white blood cell found in the bone marrow. Although it is highly treatable, many people are still unfamiliar with myeloma or may confuse it with melanoma.

Greater awareness can help support earlier recognition, diagnosis and access to care.

This September, let’s make sure more people know myeloma by name.

Learn more about multiple myeloma: https://touchhaematology.com/speciality/myeloma/

🧬 Inside SIOPE 2026: Key insights and late-breaking dataLeading experts gathered in Glasgow for the 16th CCI Europe Conf...
01/09/2026

🧬 Inside SIOPE 2026: Key insights and late-breaking data

Leading experts gathered in Glasgow for the 16th CCI Europe Conference and 7th SIOP Europe Annual Meeting, highlighting how collaboration is reshaping paediatric oncology across research, trials and patient care.

Key themes included patient-reported outcomes, cross-border trial networks, early-phase drug development, psychosocial care, mentorship and the growing role of digital innovation and immunotherapy in childhood cancer.

Explore the full coverage:
https://touchoncology.com/insight/sp-inside-siope-2026/

Address


Website

Alerts

Be the first to know and let us send you an email when Touch Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Touch Oncology:

Shortcuts

  • Want your business to be the top-listed Media Company?

Share